The results obtained indicated that elevated HOTTIP (Liu et al., 2020) and HAGLR (Liu et al., 2019) expression levels could predict poor prognosis in cancer patients, suggesting that HOTTIP and HAGLR might serve as novel prognostic biomarkers for cancer (Supplementary Figure S19). The gene discussed is HOTTIP; the disease is cancer.